Free Trial
TSE:FRX

Fennec Pharmaceuticals (FRX) Stock Price, News & Analysis

Fennec Pharmaceuticals logo
C$11.31 +0.21 (+1.89%)
As of 05/28/2025 03:50 PM Eastern

About Fennec Pharmaceuticals Stock (TSE:FRX)

Key Stats

Today's Range
C$11.31
C$11.38
50-Day Range
C$7.02
C$11.50
52-Week Range
C$5.65
C$11.50
Volume
253 shs
Average Volume
1,265 shs
Market Capitalization
C$218.11 million
P/E Ratio
N/A
Dividend Yield
2.02%
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Receive FRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

FRX Stock News Headlines

HC Wainwright Analysts Boost Earnings Estimates for TSE:FRX
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Wedbush Lifts Earnings Estimates for Fennec Pharmaceuticals
Fennec reports Q4 EPS (6c), consensus (13c)
See More Headlines

FRX Stock Analysis - Frequently Asked Questions

Fennec Pharmaceuticals' stock was trading at C$8.87 at the beginning of 2025. Since then, FRX stock has increased by 27.5% and is now trading at C$11.31.
View the best growth stocks for 2025 here
.

Fennec Pharmaceuticals Inc. (TSE:FRX) released its quarterly earnings results on Thursday, November, 7th. The biopharmaceutical company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.19) by $0.10. Fennec Pharmaceuticals had a negative net margin of 2.30% and a positive trailing twelve-month return on equity of 29.94%.

Shares of FRX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fennec Pharmaceuticals investors own include Tilray (TLRY), Aurora Cannabis (ACB), Encanto Potash (EPO), Fennec Pharmaceuticals (FENC), Ocugen (OCGN), Passport Potash (PPI) and Workhorse Group (WKHS).

Company Calendar

Last Earnings
11/07/2024
Today
5/29/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:FRX
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
18.73
P/E Growth
N/A
Net Income
-C$800.44 thousand
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$34.86 million
Cash Flow
C$0.97 per share
Price / Cash Flow
11.66
Book Value
C($0.19) per share
Price / Book
-59.70

Miscellaneous

Free Float
N/A
Market Cap
C$218.11 million
Optionable
Not Optionable
Beta
0.25
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (TSE:FRX) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners